EQT Life Sciences’ portfolio company Cardior Pharmaceuticals to be acquired by Novo Nordisk read full story

EQT Life Sciences has supported Amolyt since its first investment in 2019 read full story

EQT Life Sciences Leads Tubulis’ Upsized €128 Million Series B2 Financing read full story

EQT Life Sciences leads $42M funding round in Phagenesis read full story

EQT LIFE SCIENCES LEADS €30M SERIES C FUNDING ROUND IN ONERA read full story

EQT LS portfolio company Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round read full story

go to archive